Paul Michael Ness

Paul Michael Ness's AcademicInfluence.com Rankings

Paul Michael Ness

Philosophy

#8158

World Rank

#11484

Historical Rank

Logic

#5189

World Rank

#6568

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Paul Michael Ness's Degrees

Doctorate Medicine Harvard University

Why Is Paul Michael Ness Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paul Michael Ness's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. (1991) (828)
The declining risk of post-transfusion hepatitis C virus infection. (1992) (705)
Dose of prophylactic platelet transfusions and prevention of hemorrhage. (2010) (519)
Effects of red-cell storage duration on patients undergoing cardiac surgery. (2015) (402)
The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion‐related acute lung injury risk reduction strategy (2009) (304)
Septic reactions to platelet transfusions. A persistent problem. (1991) (232)
The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long‐term serologic findings, and clinical significance (1990) (216)
The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. (2002) (213)
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure (2002) (205)
Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs (2004) (190)
Variability in Blood and Blood Component Utilization as Assessed by an Anesthesia Information Management System (2012) (178)
The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public (2002) (162)
Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. (2015) (162)
Indications for and Adverse Effects of Red-Cell Transfusion. (2017) (160)
Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection. (2015) (156)
Whole blood for hemostatic resuscitation of major bleeding (2016) (149)
Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction (2011) (141)
Knowledge, attitude and practice survey regarding blood donation in a Northwestern Chinese city (2005) (136)
Blood banking in China (2002) (134)
Trauma Hemostasis and Oxygenation Research Position Paper on Remote Damage Control Resuscitation: Definitions, Current Practice, and Knowledge Gaps (2014) (131)
The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia. (2012) (117)
Association of Perioperative Red Blood Cell Transfusions With Venous Thromboembolism in a North American Registry (2018) (116)
Optimizing Preoperative Blood Ordering with Data Acquired from an Anesthesia Information Management System (2013) (116)
Drone transportation of blood products (2017) (114)
Decreased Erythrocyte Deformability After Transfusion and the Effects of Erythrocyte Storage Duration (2013) (112)
Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors - An assessment of the efficacy of testing in donor screening (1990) (110)
Low Titer Group O Whole Blood in Emergency Situations (2014) (104)
Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication (2016) (99)
MOLLISON'S BLOOD TRANSFUSION IN CLINICAL MEDICINE, 11TH ED. (2007) (96)
Transfusion‐associated hyperkalemic cardiac arrest in pediatric patients receiving massive transfusion (2014) (95)
Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections. (1992) (91)
A novel method of data analysis for utilization of red blood cell transfusion (2013) (90)
Current status of microbial contamination of blood components: summary of a conference (1997) (89)
Possible transmission of human herpesvirus‐8 by blood transfusion in a historical United States cohort (2005) (87)
Depletion of white cells from platelet concentrates with a new adsorption filter (1989) (85)
ABO antibody titers are not predictive of hemolytic reactions due to plasma‐incompatible platelet transfusions (2012) (85)
Refrigerated Platelets for the Treatment of Acute Bleeding: A Review of the Literature and Reexamination of Current Standards (2014) (84)
The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS‐III): a research program striving to improve blood donor and transfusion recipient outcomes (2014) (82)
Blood wastage reduction using Lean Sigma methodology (2010) (81)
Current problems and future directions of transfusion‐induced alloimmunization: summary of an NHLBI working group (2011) (80)
Transfusion‐related adverse events in the Platelet Dose study (2015) (80)
Patient safety and blood transfusion: new solutions. (2003) (80)
The critical role of plasmapheresis in ABO‐incompatible renal transplantation (2008) (79)
Blood Banking and Transfusion Medicine: Basic Principles and Practice (2006) (78)
The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME) (2014) (78)
Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow. (1982) (76)
Single donor versus pooled random donor platelet concentrates (2001) (74)
Consensus recommendations for the off-label use of recombinant human factor VIIa (NovoSeven®) therapy (2005) (73)
Red blood cells stored 35 days or more are associated with adverse outcomes in high‐risk patients (2016) (70)
Genetic factors predisposing to autoimmune diseases. Autoimmune hemolytic anemia, chronic thrombocytopenic purpura, and systemic lupus erythematosus. (1982) (68)
Reducing Unnecessary Preoperative Blood Orders and Costs by Implementing an Updated Institution-specific Maximum Surgical Blood Order Schedule and a Remote Electronic Blood Release System (2014) (68)
Cost‐effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients (2014) (67)
The utility of platelet washing using an automated procedure for severe platelet allergic reactions (1987) (67)
Implementing a Health System–wide Patient Blood Management Program with a Clinical Community Approach (2017) (66)
TRANSFUSION PRACTICE: Toward extended phenotype matching: a new operational paradigm for the transfusion service (2009) (66)
N‐terminal pro‐brain natriuretic peptide is a useful diagnostic marker for transfusion‐associated circulatory overload (2008) (66)
Donor return after temporary deferral (2011) (65)
Transfusion premedications: a growing practice not based on evidence (2007) (64)
Clinical high-risk designation does not predict excess fetal-maternal hemorrhage. (1987) (64)
Predictors of transfusion for spinal surgery in Maryland, 1997 to 2000 (2002) (63)
The predictive value of crossmatching platelet transfusion for alloimmunized patients (1985) (62)
Treatment of autoimmune hemolytic anemia. (2005) (62)
Therapeutic plasma exchange reduces ABO titers to permit ABO‐incompatible renal transplantation (2009) (61)
A randomized, placebo-controlled trial of intravenous gammaglobulin in alloimmunized thrombocytopenic patients. (1990) (61)
Blood transfusion safety in sub‐Saharan Africa: A literature review of changes and challenges in the 21st century (2018) (61)
Risk‐adjusted clinical outcomes in patients enrolled in a bloodless program (2014) (60)
Hepatitis E virus seroprevalence and molecular study among blood donors in China (2014) (59)
What price progress?: An update on vinyl plastic blood bags (1989) (58)
Scratching the surface of allergic transfusion reactions (2013) (57)
Evidence of Trypanosoma cruzi Infection (Chagas’ Disease) Among Patients Undergoing Cardiac Surgery (2000) (57)
Studies on the pathophysiology of posttransfusion purpura. (1986) (56)
Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes (2011) (56)
Blood Banking and Transfusion Medicine (2002) (56)
Morbidity and Mortality after High-dose Transfusion (2016) (55)
Cryoprecipitate as a reliable source of fibrinogen replacement. (1979) (55)
Impaired Red Blood Cell Deformability after Transfusion of Stored Allogeneic Blood but Not Autologous Salvaged Blood in Cardiac Surgery Patients (2014) (53)
TRANSFUSION COMPLICATIONS: Bacterial culture reduces but does not eliminate the risk of septic transfusion reactions to single‐donor platelets (2009) (52)
The red blood cell storage lesion: the end of the beginning (2016) (52)
Blood safety and availability: continuing challenges in China's blood banking system (2013) (52)
Blood Donor Management in China (2014) (52)
Efficacy of autologous fresh whole blood or platelet‐rich plasma in adult cardiac surgery (1995) (52)
Validating billing data for RBC transfusions: a brief report (2001) (51)
Red blood cell transfusion triggers in acute leukemia: a randomized pilot study (2016) (51)
Efficacy of education followed by computerized provider order entry with clinician decision support to reduce red blood cell utilization (2015) (51)
Transmission of HIV by transfusion of screened blood. (1990) (50)
Autologous serum eyedrops: literature review and implications for transfusion medicine specialists (2008) (49)
Autoimmune hemolytic anemia with reticulocytopenia. A medical emergency. (1980) (49)
A multicenter study of plasma use in the United States (2015) (48)
Convalescent transfusion for pandemic influenza: preparing blood banks for a new plasma product? (2010) (47)
To match or not to match: the question for chronically transfused patients with sickle cell anemia (1994) (47)
Patient Blood Management Program Improves Blood Use and Clinical Outcomes in Orthopedic Surgery (2018) (46)
Time course and etiology of death in patients with severe anemia (2009) (46)
Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014 (2018) (46)
The impact of apheresis platelet manipulation on corrected count increment (2012) (45)
Patient blood management: a growing challenge and opportunity (2011) (43)
IMMUNOHEMATOLOGY: Streamlining ABO antibody titrations for monitoring ABO‐incompatible kidney transplants (2009) (42)
Addressing the unmet need of life‐threatening anemia with hemoglobin‐based oxygen carriers (2017) (42)
Tn polyagglutination preceding acute leukemia. (1979) (40)
Two‐unit red cell apheresis and its potential advantages over traditional whole‐blood donation (1999) (40)
Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets (2011) (40)
Clinical outcomes in a cohort of patients with heparin‐induced thrombocytopenia (2017) (40)
A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donors. (2012) (40)
Infectious disease markers in blood donors in northern Thailand (1995) (38)
Retention of Coagulation Factors in Plasma Frozen after Extended Holding at 1–6°C (2000) (38)
Implementation of secondary bacterial culture testing of platelets to mitigate residual risk of septic transfusion reactions (2018) (38)
Relative impact of a patient blood management program on utilization of all three major blood components (2016) (37)
Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low‐resource settings (2018) (37)
Conversion to low transfusion‐related acute lung injury (TRALI)‐risk plasma significantly reduces TRALI (2012) (37)
Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease (2005) (37)
Real Age: Red Blood Cell Aging During Storage. (2019) (36)
Oxygen therapeutics: pursuit of an alternative to the donor red blood cell. (2007) (36)
Scientific Basis of Transfusion Medicine: Implications for Clinical Practice (1994) (36)
Prognostic risk‐stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012 (2016) (36)
The Leukocyte Antibody Prevalence Study‐II (LAPS‐II): a retrospective cohort study of transfusion‐related acute lung injury in recipients of high‐plasma‐volume human leukocyte antigen antibody–positive or –negative components (2011) (35)
The increasing prevalence of serologic markers for syphilis among Chinese blood donors in 2008 through 2010 during a syphilis epidemic (2012) (35)
Transfusion recipient epidemiology and outcomes research: possibilities for the future (2008) (35)
Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions (2012) (35)
Prevalence, incidence, and residual risks for transfusion‐transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors (2013) (34)
Polyethylene glycol versus low‐ionic‐strength solution in pretransfusion testing: a blinded comparison study (1994) (33)
Polymerized human Hb use in acute chest syndrome: a case report (2002) (33)
A Simple Enzyme-Immunoassay (EIA) Test for Factor VIII-Related Antigen (VIIIAGN) (1979) (33)
Reduction in potassium concentration of stored red blood cell units using a resin filter (2010) (33)
Bloodless medicine: current strategies and emerging treatment paradigms (2016) (33)
Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study (2014) (33)
Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus. (1999) (32)
Evaluation of a multiplex human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand (2007) (32)
Congenital hypofibrinogenemia and recurrent placental abruption. (1983) (31)
Defining risk factors and presentations of allergic reactions to platelet transfusion. (2014) (30)
Research opportunities for pathogen reduction/inactivation of blood components: summary of an NHLBI workshop (2009) (30)
Prevalence of HLA antibodies in transfused patients with and without red cell antibodies (2006) (30)
Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient. (1988) (30)
Analysis of Chinese donors' return behavior (2011) (30)
How do I encourage clinicians to transfuse mismatched blood to patients with autoimmune hemolytic anemia in urgent situations? (2006) (30)
The cost‐effectiveness of platelet additive solution to prevent allergic transfusion reactions (2013) (29)
Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population‐based study (2019) (29)
A radiolabeled antiglobulin test for crossmatching platelet transfusions. (1983) (29)
Allogeneic versus autologous blood transfusion and survival after radical prostatectomy (CME) (2014) (29)
A multi–Chinese blood center study testing serologic‐negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing (2007) (28)
The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb‐expressing mice (2006) (28)
Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease (2014) (28)
Effect of Epsilon Aminocaproic Acid on Red-Cell Transfusion Requirements in Major Spinal Surgery (2009) (28)
Tacrolimus-related posttransplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia. (1996) (27)
The epidemiology of platelet transfusions: an analysis of platelet use at 12 US hospitals (2017) (27)
Does transfusion of stored red blood cells cause clinically important adverse effects? A critical question in search of an answer and a plan (2011) (27)
Retention of coagulation factors in plasma frozen after extended holding at 1-6 degrees C. (2000) (26)
Selective transfusion protocols:errors and accidents waiting to happen (2001) (26)
Revisiting Blood Safety Practices Given Emerging Data about Zika Virus. (2018) (26)
The efficacy of type and screen to reduce unnecessary cross matches for obstetric patients. (1981) (26)
A radiolabeled antiglobulin test for crossmatching platelet transfusions (1983) (26)
Fatal Immune Hemolytic Anemia and Hepatic Failure Associated with a Warm‐Reacting IgM Autoantibody (1987) (25)
IgM autoagglutinins in warm autoimmune hemolytic anemia: a poor prognostic feature. (1992) (24)
Demographics of apheresis platelet donors in five blood centers in China (2012) (24)
Red blood cell transfusion in autoimmune hemolytic anemia (2003) (24)
Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026) (2019) (24)
The efficacy of performing red cell elution studies in the pretransfusion testing of patients with positive direct antiglobulin tests (1986) (23)
The human immunodeficiency virus‐1 genotype diversity and drug resistance mutations profile of volunteer blood donors from Chinese blood centers (2012) (23)
The Evolution of Perioperative Transfusion Testing and Blood Ordering (2015) (23)
Clinical predictors of postoperative hemoglobin drift (2014) (22)
Prehospital Use of Plasma: The Blood Bankers’ Perspective (2014) (22)
Detection and quantitation of fetal maternal hemorrhage utilizing an enzyme‐linked antiglobulin test (1982) (22)
Use of Uncrossmatched Erythrocytes in Emergency Bleeding Situations. (2017) (22)
Implementing a “Why give 2 when 1 will do?” Choosing Wisely campaign (2016) (22)
Association of blood donation with iron deficiency among adolescent and adult females in the United States: a nationally representative study (2019) (21)
An animal model for delayed hemolytic transfusion reactions. (2001) (21)
Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016 (2018) (21)
The epidemiology of bacterial culture–positive and septic transfusion reactions at a large tertiary academic center: 2009 to 2016 (2018) (21)
Platelet transfusion practices in immune thrombocytopenia related hospitalizations (2018) (21)
Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase (2011) (21)
Plasmapheresis for the Treatment of Repeated Early Pregnancy Wastage Associated With Anti‐P (1985) (21)
Hemostatic properties of cold‐stored whole blood leukoreduced using a platelet‐sparing versus a non–platelet‐sparing filter (2019) (21)
Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety (2009) (21)
Transfusion and component characteristics are not associated with allergic transfusion reactions to apheresis platelets (2015) (20)
Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusions (2019) (20)
First‐time donors responding to a national disaster may be an untapped resource for the blood centre (2012) (20)
Automated RBC exchange transfusion:treatment for cerebral malaria (2000) (20)
The risk of alloimmunization to c (Rh4) in R1R1 patients who present with anti‐E (1994) (20)
Who donates blood at five ethnically and geographically diverse blood centers in China in 2008 (2010) (19)
Hemolysis due to the simultaneous occurrence of passenger lymphocyte syndrome and a delayed hemolytic transfusion reaction in a liver transplant patient. (1996) (19)
Postinjection kinetics of antepartum Rh immune globulin. (1990) (19)
Probable transmission of hepatitis E virus (HEV) via transfusion in the United States (2019) (19)
Hypotensive transfusion reactions in the era of prestorage leukoreduction (2015) (18)
Interactive dashboards to support a patient blood management program across a multi‐institutional healthcare system (2016) (17)
The resolution of platelet serologic problems using Western blotting. (2008) (17)
Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease (2017) (17)
A study of seroprevalence and rates of asymptomatic viremia of severe fever with thrombocytopenia syndrome virus among Chinese blood donors (2015) (17)
The glycosphingolipid composition of the placenta of a blood group P fetus delivered by a blood group Pk1 woman and analysis of the anti-globoside antibodies found in maternal serum. (1988) (17)
An unusual factor‐X inhibitor in leprosy (1980) (17)
Demographic characteristics and risks for transfusion‐transmissible infection among blood donors in Xinjiang autonomous region, People's Republic of China (2006) (17)
Plasma clearance rates of coagulation factors VIII and IX in factor-deficient individuals. (1986) (17)
Transfusion for remote damage control resuscitation (2013) (17)
How do we prevent transfusion‐associated graft‐versus‐host disease in children? (2011) (16)
Patient blood management: a primary theme in transfusion medicine (2014) (16)
Prevention of perinatal transmission of hepatitis B virus: the sensitivity, specificity, and predictive value of the recommended screening questions to detect high-risk women in an obstetric population. (1987) (16)
Development of a risk‐adjusted blood utilization metric (2014) (16)
Blood Product Utilization Among Trauma and Nontrauma Massive Transfusion Protocols at an Urban Academic Medical Center (2017) (15)
Antigen-matched red blood cell transfusions for patients with sickle cell disease at The Johns Hopkins Hospital (2012) (15)
Estimation of transfused red cell survival using an enzyme‐linked antiglobulin test (1985) (15)
Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers (2015) (15)
Hemotherapy: from bloodletting magic to transfusion medicine (2006) (15)
THE SICKLE CELL HEMOLYTIC TRANSFUSION REACTION SYNDROME. AUTHORS' REPLY (1997) (15)
An analysis of risk factors for human immunodeficiency virus infection among Chinese blood donors (2013) (15)
Intraoperative hemodilution and autologous platelet rich plasma collection: two techniques for collecting fresh autologous blood. (1995) (14)
Th activation in congenital hypoplastic anemia (1987) (14)
Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing (2018) (14)
Fenoprofen-induced immune hemolysis. Difficulties in diagnosis and complications in compatibility testing. (1988) (14)
Financial analysis of large‐volume delayed sampling to reduce bacterial contamination of platelets (2020) (14)
Blood utilization and mortality in victims of gun violence (2018) (13)
Maximizing the benefits of type and screen by continued surveillance of transfusion practice. (1983) (13)
Hemoglobin thresholds for transfusion in pediatric patients at a large academic health center (2015) (13)
The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012–2014 (2017) (13)
The association of elevated alanine aminotransferase levels with hepatitis E virus infections among blood donors in China (2017) (13)
Interpretation of pathogen load in relationship to infectivity and pathogen reduction efficacy (2018) (13)
Prevention of febrile nonhemolytic and allergic transfusion reactions with pretransfusion medication: is this evidence‐based medicine? (2008) (12)
Factors associated with red blood cell, platelet, and plasma transfusions among inpatient hospitalizations: a nationally representative study in the United States (2018) (12)
Individual- and hospital-level correlates of red blood cell, platelet, and plasma transfusions among hospitalized children and neonates: a nationally representative study in the United States. (2020) (12)
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. (2012) (12)
Adverse reactions in blood donors with a history of seizures or epilepsy (1995) (12)
A microtiter plate technique for the detection of platelet antibodies and platelet antigen typing (1984) (12)
Transfusion medicine: an overview and update. (2000) (12)
Blood Transfusion Safety in Low-Resourced Countries: Aspiring to a Higher Standard (2020) (12)
Isohemagglutinin titering performed on an automated solid‐phase and hemagglutinin‐based analyzer is comparable to results obtained by manual gel testing (2020) (12)
An appeal to medical journal editors: The need for a full description of laboratory methods and specimen handling in clinical study reports (2012) (12)
Assessment of the clinical significance of anti‐Dob (2008) (12)
A multicentre study investigating vital sign changes occurring in complicated and uncomplicated transfusions (2018) (12)
A case study of a child with chronic hemolytic anemia due to a Donath–Landsteiner positive, IgM anti‐I autoantibody (2012) (11)
Red cell, platelet, and white cell antigens (2018) (11)
A simplified radioimmunoassay for antibodies causing immune cytopenia. (1985) (11)
Civilian walking blood bank emergency preparedness plan (2021) (11)
Red Cells - Aging Gracefully in the Blood Bank. (2016) (11)
The failure of postinjection Rh immune globulin titers to detect large fetal-maternal hemorrhages. (1986) (10)
Hemolytic anemias. Failure of the red cell membrane. (1976) (10)
Reviewing manuscripts: tips and responsibilities (2009) (10)
Clinical research design and reporting: always room for improvement! (2007) (10)
Perioperative Transfusions and Venous Thromboembolism (2020) (10)
The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations (2013) (10)
A rare, potentially life‐threatening presentation of passenger lymphocyte syndrome (2017) (10)
WBC alloimmunization: effects on the laboratory and clinical endpoints of therapeutic granulocyte transfusions (2018) (10)
Transfusion of leukoreduced blood products and risk of antibody‐mediated rejection of renal allografts (2018) (10)
Probenecid induced immune hemolytic anemia. (1986) (10)
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. (2012) (10)
Psychological and behavioural impacts of the 2008 China earthquake on blood donors (2010) (9)
Integrating the new generation of blood components into transfusion practice (1999) (9)
The expression of IgG allotypes on platelets and immunization to IgG allotypes in multitransfused thrombocytopenic patients. (1990) (9)
Autoimmune Hemolytic Anemia With Reticulocytopenia (2017) (9)
Therapeutic complications in acute myelogenous leukemia. (1979) (9)
Red cell Th activation: biochemical studies (1987) (9)
Joining the circle (2003) (9)
Electronic remote blood issue supports efficient and timely supply of blood and cost reduction: evidence from five hospitals at different stages of implementation (2019) (9)
Hepatitis C virus prevalence and incidence estimates among Chinese blood donors (2019) (9)
The reintroduction of nonleukoreduced blood: would patients and clinicians agree? (2011) (9)
Current approaches to red blood cell transfusion. (1996) (8)
Desensitization in allergic transfusion reactions: evidence from the Trial to Reduce Alloimmunization to Platelets (2014) (8)
The promise of extended donor antigen typing (2015) (8)
What price progress? An update on vinyl plastic bags. (1989) (8)
The diagnostic usefulness of measuring antineutrophil antibodies in neutropenic patients. (1986) (8)
Secondary bacterial culture of platelets to mitigate transfusion‐associated sepsis: A 3‐year analysis at a large academic institution (2020) (8)
The future of red blood cell alloimmunization risk reduction (2015) (8)
Plasma fractionation in the United States. A review for clinicians. (1974) (8)
Platelet transfusions: are we ready to chill out? (2017) (7)
HIV prevalence and incidence estimates among blood donors in five regions in China (2019) (7)
Use of a human polymerized hemoglobin solution as an adjunct to acute normovolemic hemodilution during complex abdominal aortic reconstruction. (2003) (7)
Bacterial contamination of blood products in Africa (2021) (7)
Blood donor testing for HIV-I/II and HTLV-I/II. (1994) (7)
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Statement by the Consortium of Laboratory Medicine Journal Editors (2012) (6)
Characterization of antibody and selection of alternative drug therapy in hydrochlorothiazide‐induced immune hemolytic anemia (1988) (6)
Risk factors for hepatitis C virus infection among blood donors in Beijing and implications for improving the pretesting donor screening process (2008) (6)
A new section on blood conservation: liberalizing TRANSFUSION (2004) (6)
Therapeutic plasma exchange for hyperviscosity syndrome secondary to high rheumatoid factor. (2018) (6)
Transfusion for remote damage control resuscitation (2013) (6)
The assessment of fetal-maternal hemorrhage by an enzyme-linked antiglobulin test for Rh immune globulin recipients. (1982) (6)
BeadChip molecular immunohematology: Toward routine donor and patient antigen profiling by DNA analysis (2011) (6)
Treating anemia. (1996) (6)
Rapid infusion of additive red blood cells: alternative techniques for massive hemorrhage. (1990) (6)
Parallel enzyme‐linked immunosorbent assay screening for human immunodeficiency virus among blood donors in five Chinese blood centres: a retrospective analysis (2015) (6)
The broken reimbursement system: putting the brakes on the blood safety train (2003) (6)
Plasma trial: Pilot randomized clinical trial to determine safety and efficacy of plasma transfusions (2021) (6)
Packed Red Blood cells and Related Products (2007) (6)
Long‐term return behavior of Chinese whole blood donors (2013) (6)
Chorionic villus sampling for fetal Rh typing: clinical implications. (1992) (6)
Blood transfusion trends in the United States: national inpatient sample, 2015 to 2018 (2021) (6)
Erythropoietin and preoperative blood donation. (1990) (6)
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports (2012) (5)
Acute renal failure with hemolysis in a D‐mismatched transfusion recipient treated with RhIG (2009) (5)
The need for an artificial oxygen carrier for disasters and pandemics, including COVID‐19 (2020) (5)
Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors (2011) (5)
Abnormalities of the spleen and liver in patients with hemophilia (1983) (5)
Pharmacologic Alternatives to Transfusion (2002) (5)
The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014–2017 (2020) (5)
Solvent detergent treated pooled plasma and reduction of allergic transfusion reactions (2019) (4)
The safety of the blood supply. (2011) (4)
Methods of Bloodless Care, Clinical Outcomes, and Costs for Adult Patients Who Decline Allogeneic Transfusions (2022) (4)
Two‐Unit Red Cell Transfusions in Stable Anemic Patients (2017) (4)
An incremental solution to bacterial contamination: taking the first step (2004) (4)
CONSORT comes to TRANSFUSION (2009) (4)
Re-evaluation of plasmas from patients previously diagnosed as having von Willebrand's disease with the factor VIII-related antigen and ristocetin cofactor assay. (1979) (4)
One‐unit compared to two‐unit platelet transfusions for adult oncology outpatients (2019) (4)
How do you… decide which platelet bacterial risk mitigation strategy to select for your hospital‐based transfusion service? (2020) (4)
Single donor platelets versus whole blood derived platelets: are they the same? (2020) (3)
The Du phenotype, serology, and clinical relevance. (1984) (3)
Platelet corrected count increments by apheresis platform (2016) (3)
Adverse Effects of Red-Cell Transfusion. (2018) (3)
Characteristics of Transfused Platelets Do Not Affect Bleeding Outcomes in Hypoproliferative Thrombocytopenia. (2009) (3)
Long‐term 51Cr survival of serologically incompatible red cell units (1985) (3)
Novel management of cold agglutinin disease (2003) (3)
Comparison of antibody elution techniques by enzyme‐linked antiglobulin test (1983) (3)
Efficacy of washed platelets for the treatment of severe allergic transfusion reactions (2001) (3)
Current risk factors for HIV infection among blood donors in seven Chinese regions (2020) (3)
The National Blood Resource Program Adenine Experience (1974) (3)
Liberal Vs. Restrictive Transfusion Thresholds in Leukemia Patients: A Feasibility Pilot Study (2015) (3)
Comparative changes of pre‐operative autologous transfusions and peri‐operative cell salvage in the United States (2020) (3)
Leukocyte reduction of red cells when transfusing patients with autoimmune hemolytic anemia: a strategy to decrease the incidence of confounding transfusion reactions (1996) (3)
Limiting the chaos of same‐day surgery (2006) (3)
Full disclosure in industry-sponsored laboratory medicine research studies: Statement by the Consortium of Laboratory Medicine Journal Editors. (2011) (3)
A Randomized Controlled Trial on the Efficacy of High-Dose Granulocyte Transfusion Therapy in Neutropenic Patients with Infection (2014) (3)
Prothrombin and Partial Thromboplastin Time (2020) (3)
Cryoprecipitate Utilization Patterns Observed With a Required Prospective Approval Process vs Electronic Dosing Guidance. (2020) (3)
Blood products for resuscitation: moving forward by going backward (2019) (3)
Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy (2022) (3)
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports (2012) (3)
Estimation of hepatitis B–positive rates in Chinese blood donors by combining predonation and postdonation screening results (2019) (2)
BOOK REVIEW (1968) (2)
The association of Tn and leukemia. (1983) (2)
CONSORT and clinical trial reporting: room for improvement (2016) (2)
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. (2012) (2)
Red cell transfusions and blood groups (2004) (2)
Full disclosure in industry‐sponsored laboratory medicine research studies: statement by the consortium of laboratory medicine journal editors (2012) (2)
Enhancing patient blood management: a long-term FOCUS (2015) (2)
Blood products for resuscitation: moving forward by going backward (2019) (2)
Regulations prohibiting blood donation by individuals with seizures or epilepsy are not necessary. (1997) (2)
Sepsis After Platelet Transfusions-Reply (1992) (2)
Maternal immunity to red cell antigens and fetal transfusion. (1992) (2)
Platelets from the refrigerator: a better way to stop bleeding? (2019) (2)
Declining prevalence of HIV-seropositive blood donors. (1989) (2)
Chapter 49 – Hemolytic Transfusion Reactions: Acute and Delayed (2007) (2)
Effect of incubation with crystalloid solutions or medications on packed red blood cells (2019) (2)
Continuous infusion therapy of factor VIII concentrate in hemophilia (1981) (2)
Prenatal ABO/RHD Genotyping: A New Paradigm to Allow for Fresh Whole Blood for Cardiopulmonary Bypass in the Immediate Newborn Period (2018) (2)
Transfusion Clips: a new section for TRANSFUSION (2012) (1)
The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial (2022) (1)
Comprar Beadchip molecular immunohematology. Toward routine donor and patient antigen profiling by dna analysis | J. Moulds | 9781441975119 | Springer (2011) (1)
Red Blood Cell Alloimmunization Is Affected by Depletion of Donor White Cell Subsets. (2007) (1)
TRANSFUSION enhancements in the digital age (2015) (1)
Supply, capacity, and demand (2016) (1)
The pursuit of platelet safety (2022) (1)
Cytomegalovirus‐safe blood: the unclear effect of sickle hemoglobin (2017) (1)
Full‐disclosure in industry‐sponsored laboratory medicine research studies: Statement by the Consortium of Laboratory Medicine Journal Editors (2011) (1)
Transfusion CME hits 50 (2014) (1)
Blood transfusions in gunshot‐wound‐related emergency department visits and hospitalizations in the United States (2021) (1)
Single‐page reports of new alleles or antigens (2013) (1)
Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. (2011) (1)
Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. (2011) (1)
First “themed issue” of TRANSFUSION on thirty years of progress in blood safety since recognition of transfusion‐associated AIDS (2013) (1)
An Appeal to Medical Journal Editors: The Need for a Full Description of Laboratory Methods and Specimen Handling in Clinical Study Reports (2012) (1)
Title: Predictors of transfusion for spinal surgery in Maryland, 1997-2000. (2001) (1)
New features for TRANSFUSION authors and readers (2007) (1)
Poverty and human development: access to a safe and adequate supply of blood for transfusion (2007) (1)
The curtain is still going up (2010) (1)
Chapter 111 – Principles of Red Blood Cell Transfusion (2017) (1)
Associations between ABO non-identical platelet transfusions and patient outcomes-A multicenter retrospective analysis. (2023) (0)
A new section, “blood group genomics,” with a new associate editor (2010) (0)
The above letter was sent to Buetens et al.; the authors offered the following reply. (2007) (0)
Herbert Asa Perkins, MD. (2013) (0)
Introduction: Recent Evolution of Transfusion Medicine (2013) (0)
Full-Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors (2011) (0)
Blood donors with epilepsy continue to face unjustified discriminatory practices (2018) (0)
Data collection: an unmet transfusion community need (2007) (0)
Masthead and Table of Contents (2017) (0)
Chapter 1 – Historical Introduction (1974) (0)
Cryoprecipitate as a Reliable Source of Fibrinogen Replacement (1980) (0)
PLATELETS AND THROMBOPOIESIS Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality (2015) (0)
Regarding Perspective Piece from July 2016 “What Do We Know About Chagas Disease in the United States?” (2017) (0)
In reply (2012) (0)
Masthead and Table of Contents (2018) (0)
Comment (2009) (0)
U.S. cities will not meet blood product resuscitation standards during major mass casualty incidents: Results of a THOR‐AABB working party prospective analysis (2022) (0)
Credit where credit is due: TRANSFUSION now offers continuing medical education (CME) to reviewers (2017) (0)
Masthead and Table of Contents (2018) (0)
Masthead and Table of Contents (2018) (0)
Alternatives to Human Blood Resources (2001) (0)
Response to “Be alert to leukocyte antibodies when prescribing granulocyte transfusions” (2019) (0)
Masthead and Table of Contents (2017) (0)
Reply (2002) (0)
hypoproliferative thrombocytopenia platelet increments and clinical bleeding in patients with The impact of platelet transfusion characteristics on posttransfusion (2012) (0)
Masthead and Table of Contents (2016) (0)
Risk-Predictors of Mortality in Hospitalized Patients with Thrombotic Thrombocytopenic Purpura: Nationally Representative Data from 2007-2011 (2014) (0)
Masthead and Table of Contents (2017) (0)
Microbiology in Blood Transfusion. A. J. John and M. A. Barbara (2009) (0)
Masthead and Table of Contents (2018) (0)
Masthead and Table of Contents (2020) (0)
K.E. King, R.S. Shirey and P. M. Ness (2004) (0)
Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. (2011) (0)
Masthead and Table of Contents (2019) (0)
Masthead and Table of Contents (2019) (0)
Masthead and Table of Contents (2017) (0)
Masthead and Table of Contents (2018) (0)
Book ReviewTransfusion Medicine (1990) (0)
Masthead and Table of Contents (2016) (0)
The failure of postinjection Rh immune globulin titers to detect large fetal-maternal hemorrhages (1987) (0)
Masthead and Table of Contents (2018) (0)
HIV molecular surveillance in Chinese blood donors (2018) (0)
Reforming health care will require a new delivery paradigm in transfusion medicine (2010) (0)
A change in the letters to the editor mailbox (2008) (0)
Resuscitating resuscitation science in TRANSFUSION (2017) (0)
Short-Term versus Long-Term Blood Storage. (2017) (0)
How Do I . . . ? Introduction (2006) (0)
Developing an in Vitro Functional Model of Allergic Transfusion Reactions (2012) (0)
Masthead and Table of Contents (2016) (0)
Continuing Medical Education Program in Transfusion (2016) (0)
Polyagglutination Preceding Acute Leukemia (2005) (0)
Masthead and Table of Contents (2020) (0)
Themed issue: immunohematology and blood group genomics (2015) (0)
Chapter 28 – Infectious Complications (2004) (0)
Chronic Transfusion Support (1998) (0)
Studies on the Pathophysiology of Posttransfusion Purpura Blood (2005) (0)
tigated in 10 families having more than one affected member. (1982) (0)
Masthead and Table of Contents (2019) (0)
Memories of Sandy Ellisor in Her Early Career (2008) (0)
Masthead and Table of Contents (2017) (0)
Masthead and Table of Contents (2017) (0)
Frequency of alloimmunization to c (Rh4) in R1R1 patients presenting with anti‐E (1996) (0)
TRANSFUSION now offers physicians continuing medical education credit (2010) (0)
Transitions (2005) (0)
Blood banking. (1981) (0)
Masthead and Table of Contents (2017) (0)
The Journal of Blood Services Management, a new administrative focus for TRANSFUSION (2009) (0)
RBC Storage Lesion: The End of the Beginning (2017) (0)
SEPSIS AFTER PLATELET TRANSFUSIONS. AUTHOR'S REPLY (1992) (0)
Emily Cooley and Tibor Greenwalt Memorial Awards and Lectureships (2018) (0)
In Memoriam-Karen E. King. (2018) (0)
Masthead and Table of Contents (2021) (0)
Scanning the Future of Transfusion Medicine (2017) (0)
REMOVING THE BLINDFOLD. AUTHORS' REPLY (1995) (0)
Compatibility testing problems using bovine thrombin treated plasma (1991) (0)
Transfusion medicine illustrated. Novel management of cold agglutinin disease. (2003) (0)
Passing the transfusion torch (2018) (0)
Masthead and Table of Contents (2019) (0)
Immunoglobulin Class Heterogeneity of Platelet Alloantibodies (1984) (0)
Validation of Administrative Data: Blood Transfusion (2000) (0)
Clinical and Pharmacoeconomic Evaluation Of Thrombin-Containing Products In the Hospital Setting (2010) (0)
Masthead and Table of Contents (2016) (0)
Masthead and Table of Contents (2019) (0)
Autoimmune hemolytic anemias and paroxysmal nocturnal hemoglobinuria (2016) (0)
Masthead and Table of Contents (2016) (0)
Masthead and Table of Contents (2018) (0)
Evidence ofTrypanosoma cruziInfection (Chagas’ Disease) Among Patients Undergoing Cardiac Surgery (2000) (0)
Masthead and Table of Contents (2017) (0)
Reply (1997) (0)
Allergic Sensitization in Transfusion Recipients, Not Blood Donors, Is a Risk Factor for Allergic Transfusion Reactions (2013) (0)
Masthead and Table of Contents (2016) (0)
Masthead and Table of Contents (2016) (0)
Compatibility testing problems associated with bovine thrombin–treated plasma (1993) (0)
First “themed issue” of TRANSFUSION on thirty years of progress in blood safety since recognition of transfusion‐associated AIDS (2013) (0)
TRANSFUSION's public access policy (2005) (0)
Masthead and Table of Contents (2016) (0)
Transitions—2014 (2014) (0)
Dedication in memoriam (2006) (0)
What science is and how it really works, by James C. Zimring, MD, PhD (2019) (0)
Reply (1995) (0)
Red cell transfusions in patients with hematologic malignancies (2013) (0)
Blood utilization in five Chinese hospitals shows low hemoglobin thresholds in medical patients (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paul Michael Ness?

Paul Michael Ness is affiliated with the following schools:

George Washington University
University of Minnesota
Johns Hopkins University